Northland Capital Markets Initiates Coverage of TriSalus Life Sciences (TLSI) with Outperform Recommendation

Fintel reports that on October 25, 2024, Northland Capital Markets initiated coverage of TriSalus Life Sciences (NasdaqGM:TLSI) with a Outperform recommendation.

admin